Navigation Links
IGI Laboratories To Present At Oppenheimer 24th Annual Healthcare Conference On December 10, 2013

BUENA, N.J., Nov. 13, 2013 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based generic topical pharmaceutical company will be presenting at the Oppenheimer 24th Annual Healthcare Conference. The Conference will take place on December 10 - 11, 2013 at the Crowne Plaza Hotel in New York, New York.


Jason Grenfell-Gardner, President and CEO and Jenniffer Collins, Chief Financial Officer of IGI Laboratories, Inc. will present on Tuesday December 10, 2013, at 4:30 PM ET.  Investors attending the conferences who wish to meet with Mr. Grenfell-Gardner and Mrs. Collins for a one-on-one meeting should contact their Oppenheimer representative or the Company.

The replay of the presentation will be webcast and will be available for 90 days online on the Investors section of the Company's website at

About IGI Laboratories, Inc.

IGI Laboratories is a generic topical pharmaceutical company.  We develop and manufacture topical formulations for the pharmaceutical, OTC, and cosmetic markets. Our mission is to be a leader in the generic topical prescription drug market.

SOURCE IGI Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. IGI Laboratories, Inc. Announces Thirteenth ANDA Submission
2. IGI Laboratories, Inc. Receives Formal US FDA Approval For Site Transfer Of Econazole Nitrate
3. IGI Laboratories Announces Third Quarter 2013 Results
4. Strong Efficacy Data Prompt Charleston Laboratories to Halt Phase 3 Study of CL-108 in Patients with Moderate to Severe Acute Pain
5. Cambridge Major Laboratories and AAIPharma Services Appoint Patrick D. Walsh as CEO of Merged Company
6. Water Street Completes Sale of AAIPharma Services to Cambridge Major Laboratories
7. American Capital Commits $391 Million in the Combination of Cambridge Major Laboratories and AAIPharma Services
8. Prometheus Laboratories Appoints Chief Executive Officer
9. IGI Laboratories, Inc. Announces Twelfth ANDA Submission
10. Nelson Laboratories to Offer Free Biocompatibility Consultations During MEDevice Forum San Diego
11. Harlan Laboratories Continues Strategic Growth with Expansion of South European Services Facility
Post Your Comments:
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):